Enlight Medical Technologies (Shanghai) Co., Ltd. is a solidly and rapidly growing international Chinese medical device platform company with a myriad of innovative strengths. Powered by acute sensitivity to clinical and market needs, and with the world’s most advanced technological innovations as our core driving force, we are committed to creating world-class high-quality products. Through the judicious fusion of independent R&D and resource integration, we aspire to continuously serve the cause of human health oriented by clinical needs.

Enlight Medical has established R&D centers in Shanghai, Beijing and Boston, USA. Holding degrees from top universities at home and abroad, our key members have decades of experience in medical device R&D and manufacturing management and serve as the continuous and efficient innovative core of the team.

We feature a broad spectrum of product pipelines covering multiple areas of innovative technology including structural heart disease treatment, endovascular disease treatment, neuromodulation and a brain-computer interface platform. At present, our company has obtained the NMPA approval for 4 Class Ⅲ medical devices including a thoracic stent graft system and a rapidly growing number of other products including a mitral valve repair system that are in both the R&D and clinical processes.

Enlight Medical has built an advanced R&D, testing and manufacturing base of more than 1,000 square meters in compliance with GMP standards. Based in China and integrated with the world’s emerging health needs, we will always adhere to the principle of benevolence and strive to remain at the forefront as a world-class technology provider and product manufacturer of innovative medical devices.